Scientists Resurrect Ancient Rubiscos to Understand Their Evolution

A team proposes that the addition of a small accessory subunit to the carbon-fixing enzyme was key to improving its catalytic properties and specificity to CO2.

Written byAlejandra Manjarrez, PhD
| 5 min read
Tree with many scattered branches.
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Likely the most abundant enzyme on Earth, Rubisco performs the vital function of fixing carbon from the environment in photosynthetic organisms. Of the four forms of Rubisco known to exist today, form I—present in cyanobacteria, some algae, and plants—has the highest specificity for carbon dioxide and the most efficient catalytic activity. Researchers reconstructed ancestral Rubisco sequences and measured how well these revived putative proteins performed in a lab setting, proposing in a study published online yesterday (October 13) in Science that form I’s improved qualities were acquired thanks to the gain of a small subunit. In the study, the authors retrace how this transition could have taken place.

Form I Rubisco is made up of eight identical catalytic large subunits and eight identical small subunits. Researchers long suspected that its enhanced ability to discriminate CO2 from the chemically similar molecule oxygen (O2) could be related to the presence of these ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • alejandra manjarrez

    Alejandra Manjarrez is a freelance science journalist who contributes to The Scientist. She has a PhD in systems biology from ETH Zurich and a master’s in molecular biology from Utrecht University. After years studying bacteria in a lab, she now spends most of her days reading, writing, and hunting science stories, either while traveling or visiting random libraries around the world. Her work has also appeared in Hakai, The Atlantic, and Lab Times.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies